Aragen, a leading provider of contract research, development, and manufacturing services for the pharmaceutical, biotechnology, agrochemicals and animal health industries, has commissioned its new formulations manufacturing facility in Hyderabad.

This state-of-the-art facility, set up at an investment of $3 million, is located at the Mallapur Campus in Hyderabad and spans over 12,000 square feet area. It is equipped to support the clinical manufacturing of a wide range of dosage forms, including oral solids, liquids, topicals, and films. 

Manni Kantipudi, CEO, Aragen Life Sciences, commented "With this expansion, we can offer our customers an even broader range of services, from early-stage development to clinical manufacturing, all from a co-located facility."

The facility is equipped with a comprehensive suite of formulation technologies, including wet granulation, roller compaction, film coating, spray drying, tableting, capsule filling, bottle filling, and blister packing. It has been strategically designed to accommodate the addition of nano-milling and hot melt extrusion capabilities by next year, ensuring that Aragen stays at the forefront of pharmaceutical innovation.

The facility has been inspected and approved by Indian regulators, the Central Drugs Standard Control Organisation (CDSCO) and the Drug Control Administration (DCA). It can accommodate flexible batch sizes ranging from 1,000 doses to 100,000 doses for solid orals and from 1 litre to 100 litres for liquids and will have a team of about 60 staff operating the facility.